It is worth emphasizing that the aforementioned relationships did not apply to cancer cells with IDH2 mutations, which implies that mutations in IDH isoforms may modulate cellular metabolism in various ways, and understanding them is extremely important for personalized therapy. This evidence concerns the gene IDH2 and cancer.